Gentium to trade on Nasdaq

By Elaine Rigoli

Tampa, Fla., May 5 - Gentium SpA's American Depositary Shares will be listed for trading on the Nasdaq, effective May 16, under the symbol "GENT."

The company's American Depositary Shares will continue to trade on the American Stock Exchange until they are delisted from the American Stock Exchange after the market closes on May 15.

Gentium is a biopharmaceutical company located in Villa Guardia, Italy, that is focused on the development of drugs derived from DNA extracted from natural sources and drugs that are synthetic derivatives, to treat and prevent a variety of vascular diseases and conditions related to cancer and cancer treatments.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.